109 related articles for article (PubMed ID: 2546384)
21. Blockade of eosinophil migration by 5-lipoxygenase and cyclooxygenase inhibition in explanted guinea pig trachealis.
Muñoz NM; Leff AR
Am J Physiol; 1995 Mar; 268(3 Pt 1):L446-54. PubMed ID: 7900826
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological profiles of a potential LTB4-antagonist, SM-9064.
Namiki M; Igarashi Y; Sakamoto K; Nakamura T; Koga Y
Biochem Biophys Res Commun; 1986 Jul; 138(2):540-6. PubMed ID: 3017332
[TBL] [Abstract][Full Text] [Related]
23. Effect of chemotactic agents on rat and guinea pig eosinophil cytotoxicity in vitro.
Musgrove NR; Cook RM
Int Arch Allergy Appl Immunol; 1988; 86(3):319-24. PubMed ID: 2841243
[TBL] [Abstract][Full Text] [Related]
24. Multiwell cap assay: a simple objective method for the assessment of leukocyte locomotion in vitro.
Evans AM; Chambers JD; Hobbs JR
Biosci Rep; 1986 Dec; 6(12):1041-7. PubMed ID: 3034351
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo chemotaxis of guinea pig leukocytes toward leukotriene B4 and its w-oxidation products.
Czarnetzki BM; Mertensmeier R
Prostaglandins; 1985 Jul; 30(1):5-11. PubMed ID: 2996056
[TBL] [Abstract][Full Text] [Related]
26. Biochemical and functional differences between eosinophils from animal species and man.
Sun FF; Crittenden NJ; Czuk CI; Taylor BM; Stout BK; Johnson HG
J Leukoc Biol; 1991 Aug; 50(2):140-50. PubMed ID: 1649240
[TBL] [Abstract][Full Text] [Related]
27. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro.
Belenky SN; Robbins RA; Rennard SI; Gossman GL; Nelson KJ; Rubinstein I
J Lab Clin Med; 1993 Oct; 122(4):388-94. PubMed ID: 7693839
[TBL] [Abstract][Full Text] [Related]
28. Comparison of leukotriene B4 and D4 effects on human eosinophil and neutrophil motility in vitro.
Spada CS; Nieves AL; Krauss AH; Woodward DF
J Leukoc Biol; 1994 Feb; 55(2):183-91. PubMed ID: 8301215
[TBL] [Abstract][Full Text] [Related]
29. Concentration-dependent activity of mometasone furoate and dexamethasone on blood eosinophils isolated from atopic children: modulation of Mac-1 expression and chemotaxis.
Sale R; Sabatini F; Silvestri M; Serpero L; Petecchia L; Rossi GA
Int Immunopharmacol; 2004 Dec; 4(13):1687-96. PubMed ID: 15454120
[TBL] [Abstract][Full Text] [Related]
30. Leukotriene B4 paradox: neutrophils can, but will not, respond to ligand-receptor interactions by forming leukotriene B4 or its omega-metabolites.
Haines KA; Giedd KN; Rich AM; Reibman J; Korchak HM; Weissmann G
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():890-9. PubMed ID: 2823576
[No Abstract] [Full Text] [Related]
31. Eosinophils recruited to the lung by segmental antigen challenge show a reduced chemotactic response to leukotriene B4.
Kim CJ; Kane GC; Zangrilli JG; Cho SK; Koh YY; Peters SP
Prostaglandins; 1994 May; 47(5):393-403. PubMed ID: 8066187
[TBL] [Abstract][Full Text] [Related]
32. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
Harvath L; Yancey KB; Katz SI
J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
[TBL] [Abstract][Full Text] [Related]
33. Reduction in human neutrophil chemotaxis by the prostacyclin analogue iloprost.
Nicolini FA; Mehta P; Lawson D; Mehta JL
Thromb Res; 1990 Aug; 59(3):669-74. PubMed ID: 1700491
[No Abstract] [Full Text] [Related]
34. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
Tsai BS; Keith RH; Villani-Price D; Haack RA; Djuric SW
J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959
[TBL] [Abstract][Full Text] [Related]
35. Modulation of eosinophil chemotactic activities to leukotriene B4 by n-3 polyunsaturated fatty acids.
Kikuchi S; Sakamoto T; Ishikawa C; Yazawa K; Torii S
Prostaglandins Leukot Essent Fatty Acids; 1998 Mar; 58(3):243-8. PubMed ID: 9610849
[TBL] [Abstract][Full Text] [Related]
36. A monoclonal antibody-inhibiting FMLP-induced chemotaxis of human neutrophils.
Cotter TG; Keeling PJ; Henson PM
J Immunol; 1981 Dec; 127(6):2241-5. PubMed ID: 7053244
[TBL] [Abstract][Full Text] [Related]
37. Contrasting responses to multiple chemotactic stimuli in transendothelial migration: heterologous desensitization in neutrophils and augmentation of migration in eosinophils.
Kitayama J; Carr MW; Roth SJ; Buccola J; Springer TA
J Immunol; 1997 Mar; 158(5):2340-9. PubMed ID: 9036983
[TBL] [Abstract][Full Text] [Related]
38. Effect of terfenadine on human eosinophil and neutrophil chemotactic response and generation of superoxide.
Eda R; Townley RG; Hopp RJ
Ann Allergy; 1994 Aug; 73(2):154-60. PubMed ID: 8067599
[TBL] [Abstract][Full Text] [Related]
39. 5-Oxo-eicosanoids are potent eosinophil chemotactic factors. Functional characterization and structural requirements.
Schwenk U; Schröder JM
J Biol Chem; 1995 Jun; 270(25):15029-36. PubMed ID: 7797484
[TBL] [Abstract][Full Text] [Related]
40. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
Fletcher MP
J Immunol; 1986 Jun; 136(11):4213-9. PubMed ID: 3009618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
